Revolution Medicines, Inc. (RVMD)
157.48
+2.85
(+1.84%)
USD |
NASDAQ |
May 29, 16:00
158.00
+0.52
(+0.33%)
After-Hours: 20:00
Revolution Medicines Shareholders Equity (Quarterly) : 1.500B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Erasca, Inc. | 393.53M |
| Tango Therapeutics, Inc. | 391.51M |
| Kymera Therapeutics, Inc. | 1.540B |
| Replimune Group, Inc. | 210.54M |
| Arrowhead Pharmaceuticals, Inc. | 613.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.254B |
| Total Liabilities (Quarterly) | 753.82M |
| Debt to Equity Ratio | 0.2915 |
| Current Ratio | 6.795 |
| Net Debt Paydown Yield | -0.31% |